WASHINGTON, D.C. – Congressman Jim Matheson co-sponsored a bipartisan bill aimed at strengthening the safety of America’s prescription drug supply. The Safeguarding America’s Pharmaceuticals Act passed the U.S. House of Representatives today.
The bill, introduced with Bob Latta, R-Ohio, is aimed at preventing stolen and counterfeit medication from entering our country’s drug supply by establishing a national standard of tracing requirements for manufacturers, wholesale distributors, pharmacies, and repackagers.
“Today’s vote is the product of several years of collaboration and compromise,” Matheson said. “Currently, regulations are not efficient and vary by state. This bill creates a uniform, electronic unit-level tracking system to ensure greater patient safety for all Americans.”
The Safeguarding Pharmaceuticals Act, if passed by the Senate, will establish a collaborative process between the Food and Drug Administration and industry on establishing protocols for traceability at no additional cost to consumers.
“This bill is about protecting American families against counterfeit drugs and eliminate millions of dollars worth of duplicative government regulations that are already in place,” Matheson said. “I look forward to working with the Senate in advancing this bill forward.”
The entire text of the bill as published by Thomas for The Library of Congress: US Bill HR 1919 Safeguarding America’s Pharmaceuticals Act
Submitted in substantive part by the Offices of Rep. Jim Matheson